Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Thompson Peter A
Relationship:   Director
City:   Bellevue
State:   WA
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   385,419    

Indirect Shares

   41,741,947      
Direct Value   $0    

Indirect Value

   $302,052,442      
Total Shares   42,127,366      
Total Value   $302,052,442      


Trubion Pharmaceuticals, Inc $0 Trubion Pharmaceuticals, Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    4    

     Stock price went up :
    1   
    2    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   19.0%
 337.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Trubion Pharmaceuticals, Inc TRBN President and CEO, Dir... 2009-05-22 385,419 2009-05-22 1,000    Premium*  
            Sierra Oncology Inc SRRA Director 2015-07-21 0 2015-07-21 1,989,949    Premium*  
            Adaptimmune Therapeutics PLC ADAP Director 0 2018-06-06 4,901,310    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS Director, 10% Owner 2016-03-29 0 2021-09-20 6,943,654    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2017-07-24 0 2024-01-11 2,680,496    Premium*  
            Synthorx, Inc. THOR Director, 10% Owner 2018-12-11 0 2020-01-23 0    Premium*  
            Prevail Therapeutics Inc. PRVL Director, 10% Owner 0 2021-01-22 0    Premium*  
            Pmv Pharmaceuticals, Inc. PMVP Director, 10% Owner 2020-09-29 0 2020-09-29 114,039    Premium*  
            Silverback Therapeutics, Inc. SBTX Director 0 2023-08-29 9,240,887    Premium*  
            Decibel Therapeutics, Inc. DBTX Director, 10% Owner 2021-02-17 0 2021-02-17 883,418    Premium*  
            Edgewise Therapeutics, Inc. EWTX Director, 10% Owner 0 2024-01-23 14,756,096    Premium*  
            Janux Therapeutics, Inc. JANX Director 2021-12-16 0 2021-12-29 231,098    Premium*  
* Premium Members only  

Records found :    71         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2016-01-01 3 IO $0.00 $0 I/I 0 28,041,004 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2016-05-20 4 B $10.04 $24,096 I/I 2,400 28,043,404 2.1 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2016-05-23 4 B $10.40 $12,392,640 I/I 1,191,600 29,235,004 2.1 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2016-05-24 4 B $10.48 $5,432,832 I/I 518,400 29,753,404 2.1 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2017-03-27 4 B $4.20 $4,999,999 I/I 1,190,476 6,149,377 2.1 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-03-27 4 S $11.50 $11,684,966 I/I (1,016,084) 5,133,293 0 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-03-29 4 S $11.53 $368,764 I/I (31,983) 5,101,310 0 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-05-14 4 S $13.50 $139,050 I/I (10,300) 5,091,010 0 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-05-30 4 S $13.52 $1,635,920 I/I (121,000) 4,970,010 0 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-06-01 4 S $13.49 $674,500 I/I (50,000) 4,920,010 0 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-06-04 4 S $13.57 $232,047 I/I (17,100) 4,902,910 0 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-06-06 4 S $13.49 $21,584 I/I (1,600) 4,901,310 0 -
ALPN Alpine Immune Sciences In... Director   –       •       •   2017-07-24 4 A $0.00 $0 I/I 3,298,516 3,298,516 0 -
ALPN Alpine Immune Sciences In... Director   –       •       •   2019-01-18 4 B $5.37 $1,999,997 I/I 372,439 3,670,955 2.25 -
ALPN Alpine Immune Sciences In... Director   –       •       •   2020-12-28 4 S $14.25 $8,550,000 I/I (600,000) 3,070,955 0 %
ALPN Alpine Immune Sciences In... Director   –       •       •   2021-09-17 4 B $9.40 $9,499,988 I/I 1,010,637 425,531 2.25 %
ALPN Alpine Immune Sciences In... Director   –       •      –    2023-12-27 4 S $19.96 $3,622,700 I/I (181,498) 406,609 0 %
ALPN Alpine Immune Sciences In... Director   –       •      –    2023-12-28 4 S $18.32 $25,049,034 I/I (1,364,849) 264,315 0 %
ALPN Alpine Immune Sciences In... Director   –       •      –    2024-01-11 4 OE $12.74 $1,850,498 I/I 145,251 2,416,181 0 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-03-29 4 A $0.00 $0 I/I 4,708,450 4,708,450 0 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-03-29 4 B $15.00 $8,250,000 I/I 550,000 5,258,450 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-05-18 4 B $11.55 $48,510 I/I 4,200 5,262,650 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-05-19 4 B $12.11 $31,525 I/I 2,600 5,265,250 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-05-20 4 B $13.09 $61,732 I/I 4,716 5,269,966 2.25 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2016-06-09 4 B $12.95 $388,500 I/I 30,000 5,299,966 2.25 -
  71  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us